Financial Analyst - Saudi National

gsk; Riyadh Region; Vor Ort; SAR 70.000 - 110.000; Vollzeit

Zusammenfassung

GSK Saudi Arabia is seeking a Financial Analyst to support end-to-end reporting, tracking, and monitoring of SG&A spend. This includes monthly tracking of Advertising & Promotion (A&P) /Scientific Engagement (SE) spend activity by category, aligning with business and medical functions on YTD/YTG spend, with gap/phasing analysis.

The role will involve close collaboration with C&C HUB during ME closing and supporting planning activities with forecasting and financial planning, using Power BI and

Qualifikationen

• Saudi National
• Bachelor’s degree in accounting or finance
• SOCPA member is mandatory
• Finance qualifications: SOCPA/CA/ACCA/CPA/CFA/CMA/CIMA
• 1–3 years of corporate finance experience
• Experience in pharmaceutical industry preferred
• Advanced Excel and PowerPoint skills
• Fluent in English and Arabic

Aufgaben

• Close and control activities for P&L, budget vs actuals, and regional commentary
• Provide monthly and ad hoc financial reports for management
• Improve reporting processes and automate systems
• Support planning cycles with accurate financial plans and forecasts
• Collaborate with commercial teams to capture market dynamics and SG&A allocations
• Be hands-on with analytical tools to support the business

Kenntnisse

English language

Arabic language

Strong communication

Teamwork

Adaptability

Ausbildung

Bachelor’s degree in accounting or finance

SOCPA member

SOCPA/CA/ACCA/CPA/CFA/CMA/CIMA

Tools

Power BI

Excel

PowerPoint

Jobbeschreibung

GSK Saudi Arabia is committed to supporting Vision 2030 and the Saudi Arabian National Agenda including Saudization in line with the hiring and the training and development of Saudi National capability.

GSK Saudi Arabia is committed to supporting Vision 2030 and the Saudi Arabian National Agenda including Saudization in line with the hiring and the training and development of Saudi National capability.

Job Purpose

The Financial Analyst will be responsible for supporting end-to-end reporting, tracking, and monitoring of SG&A spend. This includes monthly tracking of Advertising & Promotion (A&P) /Scientific Engagement (SE) spend activity by category, aligning with business and medical functions on YTD/YTG spend, with gap/phasing analysis. The role will involve working closely with the Close & Control (C&C) HUB during the ME closing and supporting the FBP in managing sign‑off commentaries with the Planning HUB.

The role will also support the FBP during the monthly close and control activities, primarily related to capturing accurate SG&A by ensuring strong alignment with the C&C HUB. This will ensure completeness of accruals and accuracy of numbers with respect to spend allocation across business units.

Additionally, the Financial Analyst will support the Senior Finance Business Partner (SFP) during planning cycles to ensure accurate submission of financial plans, updates, forecasts, and all ancillary activities associated with the planning exercise. The role will involve close collaboration with the commercial team in developing financial plans and updates.

Your Key Responsibilities

This role will provide YOU the opportunity to lead key activities to progress YOUR career, these responsibilities include some of the following…

Reporting and Analysis:

• Supervising close and control activities on profit and loss, monitoring budget vs actual P&L and submitting commentaries to regional teams.
• Providing visibility to the management on performance and spend by providing monthly and adhoc financial reports per requirement.
• Process improvement initiatives on all reporting and system automation to minimize manual work and efficient reporting that support decision making

Business Partnering:

• Carrying out all ancillary planning activities including and not limited to plan phasing (calendarization), exchange and cost flips, submission of plan in financial planning system, preparing GEM offline templates and presentations.
• Support Senior finance partner (SFP) in Core commercial cycle (CCC) with preparing summary for movements Vs. last cycles for SFP & FD ensuring active participation of finance by bringing in stock position, YTD / YTG growth, capturing market dynamics for competitive analysis etc.
• Tracking actual Gross-to-Net (G2N) reflections with focus analysis of variance Vs. plan and forecast (CCC)
• Reviewing SG&A aiming to make recommendations for cost savings.
• Supporting management / business units in provision of financials pertaining to business needs.
• Supporting and at times lead commercial initiatives to bring in operational efficiencies in SG&A.
• Be hands‑on with analytical tools (Power BI etc.) to support core business team with data points and leads to action accordingly.

Why you?

Job Qualifications:

We are looking for professionals with these required skills to achieve our goals:

• Saudi National.
• Bachelor’s degree of accounting or finance is required.
• SOCPA Member is mandatory.
• Preferred Finance qualification: SOCPA/CA/ACCA/CPA/CFA/CMA/CIMA.
• 1-3 years of corporate finance and/or Big 4 experience required.
• Experience in the pharmaceutical industry is preferred.
• Advanced excel and power point skills.
• Written and spoken fluency in English and Arabic.
• The Candidate Must be Located in Riyadh.

Interpersonal skills

• Clear Communication: Strong verbal, written, and listening skills.
• Teamwork: Collaborative and goal oriented.
• Conflict Resolution: Diplomatic and empathetic.
• Adaptability: Flexible and relationship focused.

Essential Skills and Abilities:

• Understanding of commercial operations, reporting, IFRS, auditing, FP&A and business partnering.

Closing date for applications: 14 October 2026

Skills

Business Reporting Tools, Data Storytelling, Digital Fluency, Financial Modeling, Financial Performance Improvement, Influencing Without Authority, Insight Generation, Problem Solving

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.